메뉴 건너뛰기




Volumn 6, Issue 10, 2011, Pages

Warfarin anticoagulation exacerbates the risk of hemorrhagic transformation after rt-PA treatment in experimental stroke: Therapeutic potential of PCC

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; BLOOD CLOTTING FACTOR 9 CONCENTRATE; PROTHROMBIN COMPLEX; WARFARIN; ANTICOAGULANT AGENT; PROTHROMBIN; RECOMBINANT PROTEIN; TISSUE PLASMINOGEN ACTIVATOR;

EID: 80054805311     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026087     Document Type: Article
Times cited : (23)

References (22)
  • 1
    • 77952112006 scopus 로고    scopus 로고
    • Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials
    • Lees KR, Bluhmki E, von Kummer R, Brott TG, Toni D, et al. (2010) Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 375: 1695-703.
    • (2010) Lancet , vol.375 , pp. 1695-1703
    • Lees, K.R.1    Bluhmki, E.2    von Kummer, R.3    Brott, T.G.4    Toni, D.5
  • 2
    • 0037418038 scopus 로고    scopus 로고
    • Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke
    • Montaner J, Molina CA, Monasterio J, Abilleira S, Arenillas JF, et al. (2003) Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke. Circulation 107: 598-603.
    • (2003) Circulation , vol.107 , pp. 598-603
    • Montaner, J.1    Molina, C.A.2    Monasterio, J.3    Abilleira, S.4    Arenillas, J.F.5
  • 3
    • 34247844511 scopus 로고    scopus 로고
    • Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups:
    • the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists
    • Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, et al. (2007) Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 38: 1655-1711.
    • (2007) Stroke , vol.38 , pp. 1655-1711
    • Adams Jr., H.P.1    del Zoppo, G.2    Alberts, M.J.3    Bhatt, D.L.4    Brass, L.5
  • 4
    • 77952271191 scopus 로고    scopus 로고
    • Symptomatic Intracerebral Hemorrhage Among Eligible Warfarin-Treated Patients Receiving Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke
    • Prabhakaran S, Rivolta J, Vieira J, Rincon F, Stillman J, et al. (2010) Symptomatic Intracerebral Hemorrhage Among Eligible Warfarin-Treated Patients Receiving Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke. Arch Neurol 67: 559-63.
    • (2010) Arch Neurol , vol.67 , pp. 559-563
    • Prabhakaran, S.1    Rivolta, J.2    Vieira, J.3    Rincon, F.4    Stillman, J.5
  • 5
    • 33746954539 scopus 로고    scopus 로고
    • Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational study
    • O'Donnell M, Oczkowski W, Fang J, Kearon C, Silva J, et al. (2006) Preadmission antithrombotic treatment and stroke severity in patients with atrial fibrillation and acute ischaemic stroke: an observational study. Lancet Neurol 5: 749-754.
    • (2006) Lancet Neurol , vol.5 , pp. 749-754
    • O'Donnell, M.1    Oczkowski, W.2    Fang, J.3    Kearon, C.4    Silva, J.5
  • 6
    • 78149485221 scopus 로고    scopus 로고
    • Worse Outcomes and Guideline-Driven Care - Reply
    • Prabhakaran S, Chong JY, (2010) Worse Outcomes and Guideline-Driven Care - Reply. Arch Neurol 67: 1414.
    • (2010) Arch Neurol , vol.67 , pp. 1414
    • Prabhakaran, S.1    Chong, J.Y.2
  • 7
    • 79954853203 scopus 로고    scopus 로고
    • Increased risk of hemorrhagic transformation in ischemic stroke occurring during warfarin anticoagulation - An experimental study in mice
    • Pfeilschifter W, Spitzer D, Czech-Zechmeister B, Steinmetz H, Foerch C, (2011) Increased risk of hemorrhagic transformation in ischemic stroke occurring during warfarin anticoagulation - An experimental study in mice. Stroke 42: 1116-1121.
    • (2011) Stroke , vol.42 , pp. 1116-1121
    • Pfeilschifter, W.1    Spitzer, D.2    Czech-Zechmeister, B.3    Steinmetz, H.4    Foerch, C.5
  • 8
    • 7644227043 scopus 로고    scopus 로고
    • Mechanisms of Hemorrhagic Transformation After Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke
    • Wang X, Tsuji K, Lee S, Ning M, Furie K, et al. (2004) Mechanisms of Hemorrhagic Transformation After Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke. Stroke 35: 2726-2730.
    • (2004) Stroke , vol.35 , pp. 2726-2730
    • Wang, X.1    Tsuji, K.2    Lee, S.3    Ning, M.4    Furie, K.5
  • 9
    • 0002665890 scopus 로고
    • Fibrinolysis and the control of hemostasis
    • In: Stamatoyannopoulos G, Nienhui AW, Majerus PW, Varmus H, editors, Philadelphia: Saunders, 2nd edition
    • Collen D, Lijnen HR, (1994) Fibrinolysis and the control of hemostasis. In: Stamatoyannopoulos G, Nienhui AW, Majerus PW, Varmus H, editors. The molecular basis of blood diseases. 2nd edition. Philadelphia: Saunders pp. 662-88.
    • (1994) The molecular basis of blood diseases , pp. 662-688
    • Collen, D.1    Lijnen, H.R.2
  • 10
    • 84861199979 scopus 로고    scopus 로고
    • Prescription informations for coumadin® (warfarin sodium) from Brystol-Myers Squibb
    • Prescription informations for coumadin® (warfarin sodium) from Brystol-Myers Squibb. http://packageinserts.bms.com/pi/pi_coumadin.pdf.
  • 11
    • 7644223379 scopus 로고    scopus 로고
    • Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption
    • Warach S, Latour LL, (2004) Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption. Stroke 35: 2659-2661.
    • (2004) Stroke , vol.35 , pp. 2659-2661
    • Warach, S.1    Latour, L.L.2
  • 12
    • 77958152498 scopus 로고    scopus 로고
    • Safety and outcome after thrombolytic treatment treatment in ischemic stroke patients with high-risk cardioembolic sources and prior subtherapeutic warfarin use
    • Kim YD, Lee JH, Jung YH, Choi HY, Nam CM, et al. (2010) Safety and outcome after thrombolytic treatment treatment in ischemic stroke patients with high-risk cardioembolic sources and prior subtherapeutic warfarin use. J Neurol Sci 298: 101-5.
    • (2010) J Neurol Sci , vol.298 , pp. 101-105
    • Kim, Y.D.1    Lee, J.H.2    Jung, Y.H.3    Choi, H.Y.4    Nam, C.M.5
  • 13
    • 36949024933 scopus 로고    scopus 로고
    • Feasibility of IA thrombolysis for acute ischemic stroke among anticoagulated patients
    • Janjua N, Alkawi A, Georgiadis A, Suri MF, Ibrahim MS, et al. (2007) Feasibility of IA thrombolysis for acute ischemic stroke among anticoagulated patients. Neurocrit Care 7: 152-5.
    • (2007) Neurocrit Care , vol.7 , pp. 152-155
    • Janjua, N.1    Alkawi, A.2    Georgiadis, A.3    Suri, M.F.4    Ibrahim, M.S.5
  • 14
    • 0036183415 scopus 로고    scopus 로고
    • Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate (Beriplex): efficacy and safety in 42 patients
    • Preston FE, Laidlaw ST, Sampson B, Kitchen S, (2002) Rapid reversal of oral anticoagulation with warfarin by a prothrombin complex concentrate (Beriplex): efficacy and safety in 42 patients. Br J Haematol 116: 619-24.
    • (2002) Br J Haematol , vol.116 , pp. 619-624
    • Preston, F.E.1    Laidlaw, S.T.2    Sampson, B.3    Kitchen, S.4
  • 15
    • 40949148098 scopus 로고    scopus 로고
    • Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial
    • Pabinger I, Brenner B, Kalina U, Knaub S, Nagy A, et al. (2008) Prothrombin complex concentrate (Beriplex P/N) for emergency anticoagulation reversal: a prospective multinational clinical trial. J Thromb Haemost 6: 622-31.
    • (2008) J Thromb Haemost , vol.6 , pp. 622-631
    • Pabinger, I.1    Brenner, B.2    Kalina, U.3    Knaub, S.4    Nagy, A.5
  • 16
    • 84861199119 scopus 로고    scopus 로고
    • Prescription informations for activase® (alteplase) from Genentech
    • Accessed January 16, 2011
    • Prescription informations for activase® (alteplase) from Genentech. http://www.gene.com/gene/products/information/cardiovascular/cathflo-act ivase/insert.jsp. Accessed January 16, 2011.
  • 17
    • 58149357106 scopus 로고    scopus 로고
    • Experimental model of warfarin-associated intracerebral hemorrhage
    • Foerch C, Arai K, Jin G, Park KP, Pallast S, et al. (2008) Experimental model of warfarin-associated intracerebral hemorrhage. Stroke 39: 3397-3404.
    • (2008) Stroke , vol.39 , pp. 3397-3404
    • Foerch, C.1    Arai, K.2    Jin, G.3    Park, K.P.4    Pallast, S.5
  • 18
    • 65549150444 scopus 로고    scopus 로고
    • Rapid reversal of anticoagulation reduces hemorrhage volume in a mouse model of warfarin associated intracerebral hemorrhage
    • Foerch C, Arai K, Van Cott EM, van Leyen K, Lo EH, (2009) Rapid reversal of anticoagulation reduces hemorrhage volume in a mouse model of warfarin associated intracerebral hemorrhage. J Cereb Blood Flow Metab 29: 1015-1021.
    • (2009) J Cereb Blood Flow Metab , vol.29 , pp. 1015-1021
    • Foerch, C.1    Arai, K.2    Van Cott, E.M.3    van Leyen, K.4    Lo, E.H.5
  • 19
    • 70349327371 scopus 로고    scopus 로고
    • The immunomodulatory sphingosine 1-phosphate analog FTY720 reduces lesion size and improves neurological outcome in a mouse model of cerebral ischemia
    • Czech B, Pfeilschifter W, Mazaheri-Omrani N, Strobel MA, Kahles T, et al. (2009) The immunomodulatory sphingosine 1-phosphate analog FTY720 reduces lesion size and improves neurological outcome in a mouse model of cerebral ischemia. Biochem Biophys Res Commun 389: 251-256.
    • (2009) Biochem Biophys Res Commun , vol.389 , pp. 251-256
    • Czech, B.1    Pfeilschifter, W.2    Mazaheri-Omrani, N.3    Strobel, M.A.4    Kahles, T.5
  • 20
    • 0035167706 scopus 로고    scopus 로고
    • Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats
    • Chen J, Sanberg PR, Li Y, Wang L, Lu M, Willing AE, et al. Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 2001;32: 2682-2688.
    • (2001) Stroke , vol.32 , pp. 2682-2688
    • Chen, J.1    Sanberg, P.R.2    Li, Y.3    Wang, L.4    Lu, M.5    Willing, A.E.6
  • 21
    • 79953159740 scopus 로고    scopus 로고
    • A-priori sample size calculation
    • Accessed December 1, 2010
    • A-priori sample size calculation. http://www.danielsoper.com/statcalc/calc47.aspx. Accessed December 1, 2010.
  • 22
    • 84861183479 scopus 로고    scopus 로고
    • Grubb's test for outliers (extreme studentized deviate). Accessed December 1
    • Grubb's test for outliers (extreme studentized deviate) http://www.graphpad.com/quickcalcs/grubbs2.cfm. Accessed December 1, 2010.
    • (2010)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.